With the increasing popularity of weight loss medications like Ozempic, Wegovy, and Rybelsus, manufacturers are struggling to meet the demand. The recent approval of Eli Lilly's Mounjaro, a drug already approved for diabetes but renamed for weight management, will further increase the demand. Novo Nordisk, the maker of Ozempic, Wegovy, and Rybelsus, has delayed the release of new starter doses of Wegovy to ensure that current users can continue their treatment.
However, counterfeit versions of these drugs are appearing in the market, raising concerns among doctors about their safety and effectiveness
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Reuters - 🏆 2. / 97 Read more »